First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease. [electronic resource]
Producer: 20020426Description: 1292-9 p. digitalISSN:- 0022-2623
- Adenosine Triphosphate -- metabolism
- Alzheimer Disease -- drug therapy
- Amino Acid Sequence
- Animals
- Binding, Competitive
- Calcium-Calmodulin-Dependent Protein Kinases -- antagonists & inhibitors
- Enzyme Inhibitors -- chemical synthesis
- Glycogen Synthase Kinase 3
- Glycogen Synthase Kinases
- Humans
- Molecular Sequence Data
- Rabbits
- Rats
- Structure-Activity Relationship
- Thiadiazoles -- chemical synthesis
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.